Skip Nav Destination
Issues
1 June 2017
-
Cover Image
Cover Image
Cover: People sunbathing relaxing on sunny beach. Credit: Jens Magnusson. For more information, please visit gettyimages.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care May 2017, Vol.40, 729-730. doi:https://doi.org/10.2337/dc17-ti06
Editor's Note
Profiles in Progress
Mary Tyler Moore (1936–2017): Diabetes Educator and Advocate
Diabetes Care May 2017, Vol.40, 732-735. doi:https://doi.org/10.2337/dci17-0015
Clinical Care / Education / Nutrition / Psychosocial Research
The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial
William H. Polonsky; for the DIAMOND Study Group; Danielle Hessler; for the DIAMOND Study Group; Katrina J. Ruedy; for the DIAMOND Study Group; Roy W. Beck; for the DIAMOND Study Group
Diabetes Care April 2017, Vol.40, 736-741. doi:https://doi.org/10.2337/dc17-0133
Predicting and Reducing Driving Mishaps Among Drivers With Type 1 Diabetes
Daniel J. Cox; Linda A. Gonder-Frederick; Harsimran Singh; Karen S. Ingersoll; Tom Banton; Jesse H. Grabman; Karen Schmidt; William Clarke
Diabetes Care April 2017, Vol.40, 742-750. doi:https://doi.org/10.2337/dc16-0995
Epidemiology / Health Services Research
Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample
Laura L. Ekblad; Juha O. Rinne; Pauli Puukka; Hanna Laine; Satu Ahtiluoto; Raimo Sulkava; Matti Viitanen; Antti Jula
Diabetes Care April 2017, Vol.40, 751-758. doi:https://doi.org/10.2337/dc16-2001
Emerging Technologies and Therapeutics
The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial
Diabetes Care March 2017, Vol.40, 759-763. doi:https://doi.org/10.2337/dc16-2449
Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial
Diabetes Care March 2017, Vol.40, 764-770. doi:https://doi.org/10.2337/dc16-2584
Pathophysiology / Complications
Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Ele Ferrannini; Simona Baldi; Silvia Frascerra; Brenno Astiarraga; Elisabetta Barsotti; Aldo Clerico; Elza Muscelli
Diabetes Care March 2017, Vol.40, 771-776. doi:https://doi.org/10.2337/dc16-2724
Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
John M. Lachin; Ionut Bebu; Richard M. Bergenstal; Rodica Pop-Busui; F. John Service; Bernard Zinman; David M. Nathan; for the DCCT/EDIC Research Group
Diabetes Care April 2017, Vol.40, 777-783. doi:https://doi.org/10.2337/dc16-2426
Cardiovascular and Metabolic Risk
Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy
Arash Bidadkosh; Sebastiaan P.H. Lambooy; Hiddo J. Heerspink; Michelle J. Pena; Robert H. Henning; Hendrik Buikema; Leo E. Deelman
Diabetes Care March 2017, Vol.40, 784-792. doi:https://doi.org/10.2337/dc16-2175
Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
Elsayed Z. Soliman; Jye-Yu C. Backlund; Ionut Bebu; Trevor J. Orchard; Bernard Zinman; John M. Lachin; the DCCT/EDIC Research Group
Diabetes Care March 2017, Vol.40, 793-799. doi:https://doi.org/10.2337/dc16-2050
Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators
Elisabeth Svensson; Lisbeth M. Baggesen; Søren P. Johnsen; Lars Pedersen; Helene Nørrelund; Esben S. Buhl; Christiane L. Haase; Reimar W. Thomsen
Diabetes Care April 2017, Vol.40, 800-807. doi:https://doi.org/10.2337/dc16-2271
Errata
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249
Christof M. Kazda; Ying Ding; Ronan P. Kelly; Parag Garhyan; Chunxue Shi; Chay Ngee Lim; Haoda Fu; David E. Watson; Andrew J. Lewin; William H. Landschulz; Mark A. Deeg; David E. Moller; Thomas A. Hardy
Diabetes Care April 2017, Vol.40, 808. doi:https://doi.org/10.2337/dc17-er06
Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
Tomoya Mita; Naoto Katakami; Toshihiko Shiraiwa; Hidenori Yoshii; Tomio Onuma; Nobuichi Kuribayashi; Takeshi Osonoi; Hideaki Kaneto; Keisuke Kosugi; Yutaka Umayahara; Tsunehiko Yamamoto; Kazunari Matsumoto; Hiroki Yokoyama; Mamiko Tsugawa; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada; on behalf of the Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial
Diabetes Care April 2017, Vol.40, 808. doi:https://doi.org/10.2337/dc17-er06a
Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139–148
Tomoya Mita; Naoto Katakami; Hidenori Yoshii; Tomio Onuma; Hideaki Kaneto; Takeshi Osonoi; Toshihiko Shiraiwa; Keisuke Kosugi; Yutaka Umayahara; Tsunehiko Yamamoto; Hiroki Yokoyama; Nobuichi Kuribayashi; Hideaki Jinnouchi; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada; on behalf of the Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial
Diabetes Care April 2017, Vol.40, 808. doi:https://doi.org/10.2337/dc17-er06b
Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026–2035
Julio Rosenstock; Ronnie Aronson; George Grunberger; Markolf Hanefeld; PierMarco Piatti; Pierre Serusclat; Xi Cheng; Tianyue Zhou; Elisabeth Niemoeller; Elisabeth Souhami; Melanie Davies; on behalf of the LixiLan-O Trial Investigators
Diabetes Care April 2017, Vol.40, 809. doi:https://doi.org/10.2337/dc17-er06c
Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980
Vanita R. Aroda; Julio Rosenstock; Carol Wysham; Jeffrey Unger; Diego Bellido; Guillermo González-Gálvez; Akane Takami; Hailing Guo; Elisabeth Niemoeller; Elisabeth Souhami; Richard M. Bergenstal; on behalf of the LixiLan-L Trial Investigators
Diabetes Care April 2017, Vol.40, 809. doi:https://doi.org/10.2337/dc17-er06d
Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418
Sharon D. Solomon; Emily Chew; Elia J. Duh; Lucia Sobrin; Jennifer K. Sun; Brian L. VanderBeek; Charles C. Wykoff; Thomas W. Gardner
Diabetes Care April 2017, Vol.40, 809. doi:https://doi.org/10.2337/dc17-er06e
Issues and Events
e-Letters
Observations
Diabetes Prevention Program in Youth (Insulin Superheroes Club) Pilot: Improvement in Metabolic Parameters and Physical Fitness After 16 Weeks of Lifestyle Intervention
Chantis Mantilla; Tamekia Jones; Kristina M. Decker; Andrea M. Jacobo; Sylvia Y. Sontheimer; Margaret R. Mirro; Marion E. Hare; Joan C. Han
Diabetes Care March 2017, Vol.40, e63-e64. doi:https://doi.org/10.2337/dc16-2678
Sodium–Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions
Negin Misaghian-Xanthos; Afreen I. Shariff; Kavya Mekala; Loretta R. Fearrington; Tracy L. Setji; Joseph A. Aloi; John B. Buse
Diabetes Care March 2017, Vol.40, e65-e66. doi:https://doi.org/10.2337/dc16-2591
Insulin-Induced Distant Site Lipoatrophy
Diabetes Care April 2017, Vol.40, e67-e68. doi:https://doi.org/10.2337/dc16-2385
Comments and Responses
Comment on Cummings and Cohen. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2. Diabetes Care 2016;39:924–933
Diabetes Care May 2017, Vol.40, e71-e72. doi:https://doi.org/10.2337/dc16-1482
